Disturbed Cytokine Profile in Adjuvant Arthritis – A Target of the Therapeutic Potential of Dendritic Cells Derived From Cryopreserved Precursors
DOI:
https://doi.org/10.20535/ibb.2023.7.3.285432Keywords:
adjuvant arthritis, cytokines, bone marrow mononuclear cells, cryopreservation, tolerogenic dendritic cellsAbstract
Background. One of the primary causes of rheumatoid arthritis development is the disruption of the immune system's natural tolerance to its own antigens, leading to an imbalance in the body's cytokine profile. A promising method of correcting such a condition is restoring antigen-specific tolerance, in the formation of which tolerogenic dendritic cells (tolDCs) take part.
Objective. Experimental substantiation of the possibility of correcting the cytokine profile of animals with adjuvant arthritis (AA) by using tolDCs from cryopreserved bone marrow precursors.
Methods. The study was carried out on the CBA/H mice. The development of AA was assessed using a clinical indicator – the arthritis index. The levels of pro- (TNF-a, IL-6, IFN-g) and anti-inflammatory (IL-10, IL-4) cytokines in the blood serum of AA-afflicted animals were measured before and after administration of tolDCs. These tolDCs were obtained from native (NatDCs) or cryopreserved (CryoDCs) using different methods bone marrow mononuclear cells (MNCs). On the 14th day after inducing AA, the animals received intravenous injections of tolDCs (5´105/mouse). One week later, the cytokine levels in the animals' blood serum and the arthritis index were assessed.
Results. Throughout the development of AA, a unidirectional increase in TNF-α and IL-6 levels and a reduction in the content of anti-inflammatory cytokines were observed, which was accompanied by joint swelling in the animals. CryoDCs exhibited a more pronounced corrective effect on both pro- and anti-inflammatory cytokines compared to NatDCs, as evidenced by a decrease in the arthritis index, a clinical manifestation of the pathology.
Conclusions. The possibility of correcting the disturbed cytokine profile and the clinical state of animals during the development of AA through the use of tolDCs derived from cryopreserved MNCs has been proven. Specific cryopreservation conditions for MNCs have been developed, which facilitate the generation of tolDCs from them with a greater capacity, compared to derivatives of native MNCs, to correct the cytokine profile and clinical status of animals with AA.
References
Abbasi M, Mousavi MJ, Jamalzehi S, Alimohammadi R, Bezvan MH, Mohammadi H, Aslani S. Strategies toward rheumatoid arthritis therapy; the old and the new. J Cell Physiol. 2019;234(7):10018-31. DOI: 10.1002/jcp.27860
George G, Shyni GL, Raghu KG. Current and novel therapeutic targets in the treatment of rheumatoid arthritis. Inflammopharmacology. 2020;28:1457-76. DOI: 10.1007/s10787-020-00757-9
Kondo N, Kuroda T, Kobayashi D. Cytokine networks in the pathogenesis of rheumatoid arthritis. Int J Mol Sci. 2021;22(20):10922. DOI: 10.3390/ijms222010922
McInnes IB, Schett G. Pathogenetic insights from the treatment of rheumatoid arthritis. Lancet. 2017; 389(10086):2328-37. DOI: 10.1016/S0140-6736(17)31472-1
Song H, Fang F, Tomasson G, Arnberg FK, Mataix-Cols D, Fernández de la Cruz L, et al. Association of stress-related disorders with subsequent autoimmune disease. JAMA. 2018;319(23):2388-400. DOI: 10.1001/jama.2018.7028
Kessler RC, Aguilar-Gaxiola S, Alonso J, Benjet C, Bromet EJ, Cardoso G, et al. Trauma and PTSD in the WHO world mental health surveys. Eur J Psychotraumatol. 2017;8(sup5):1353383. DOI: 10.1080/20008198.2017.1353383
Clavel C, Nogueira L, Laurent L, Iobagiu C, Vincent C, Sebbag M, Serre G. Induction of macrophage secretion of tumor necrosis factor alpha through Fcgamma receptor IIa engagement by rheumatoid arthritis–specific autoantibodies to citrullinated pro-teins complexed with fibrinogen. Arthritis Rheum. 2008;58(3):678-88. DOI: 10.1002/art.23284
Yokoyama Y, Iwasaki T, Kitano S, Satake A, Nomura S, Furukawa T, et al. IL-2-Anti-IL-2 Monoclonal antibody immune complexes inhibit collagen-induced arthritis by augmenting regulatory T cell functions. J Immunol. 2018;201(7):1899-906. DOI: 10.4049/jimmunol.1701502
Huang J, Fu X, Chen X, Li Z, Huang Y, Liang C. Promising therapeutic targets for treatment of rheumatoid arthritis. Front Immunol. 2021;12:686155. DOI: 10.3389/fimmu.2021.686155
Liu X, Jones GW, Choy EH, Jones SA. The biology behind interleukin-6 targeted interventions. Curr Opin Rheumatol. 2016;28(2):152-60. DOI: 10.1097/BOR.0000000000000255
Goltsev AM, Lutsenko OD, Yampolska KY, Gaevska YO, Bondarovych MO, Ostankova LV, et al. Correction of сytokine profile in autoimmune diseases with cryopreserved embryofetoplacental complex products. Probl Cryobiol Cryomed 2022;32(2):121-33. DOI: 10.15407/cryo32.02.121
Dominguez-Villar M, Hafler DA. Regulatory T cells in autoimmune disease. Nat Immunol. 2018;19(7):665-73. DOI: 10.1038/s41590-018-0120-4
Wang YA, Li XL, Mo YZ, Fan CM, Tang L, Xiong F, et al. Effects of tumor metabolic microenvironment on regulatory T cells. Mol Cancer. 2018 Nov 26;17(1):168. DOI: 10.1186/s12943-018-0913-y
Shmerling RH. Autoimmune disease and stress: Is there a link? [Internet] Harvard Health Publishing; 2020 [cited 2023 Jul 25]. Available from: https://www.health.harvard.edu/blog/autoimmune-disease-and-stress-is-there-a-link-2018071114230
Paradowska-Gorycka A, Wajda A, Romanowska-Prochnicka K, Walczuk E, Kuca-Warnawin E, Kmiolek T, et al. Th17/Treg-related transcriptional factor expression and cytokine profile in patients with rheumatoid arthritis. Front Immunol. 2020;11:572858. DOI: 10.3389/fimmu.2020.572858
Vvedenskiy D, Volkova N, Babenko N, Gaevska Y, Yukhta M, Goltsev AM. Role of cryopreserved multipotent mesen-chymal stromal cells in modulation of some indices of cell immunity in adjuvant arthritis. Reumatologia. 2022;60(3):213-19. DOI: 10.5114/reum.2022.117842
Kysielova H, Yampolska K, Dubrava T, Lutsenko O, Bondarovych M, Babenko N, et al. Improvement of bone marrow mononuclear cells cryopreservation methods to increase the efficiency of dendritic cell production. Cryobiology. 2022;106:122-30. DOI: 10.1016/j.cryobiol.2022.02.004
Consonni FM, Porta C, Marino A, Pandolfo C, Mola S, Bleve A, et al. Myeloid-derived suppressor cells: ductile targets in disease. Front Immunol. 2019 May 3;10:949. DOI: 10.3389/fimmu.2019.00949
Cauwels A, Tavernier J. Tolerizing strategies for the treatment of autoimmune diseases: from ex vivo to in vivo strategies. Front Immunol. 2020;11:674. DOI: 10.3389/fimmu.2020.00674
Goltsev AM, Yampolska KY, Kisielova HG, Оstankov MV, Dubrava TG, Babenko NМ, et al. Cryopreservation as biotechnological application of dendritic cells in clinical practice. Problems Cryobiol Cryomed. 2021;31(4):289-303. DOI: 10.15407/cryo31.04.289
Usero L, Miralles L, Esteban I, Pastor-Quiñones C, Maleno MJ, Leal L, et al. Feasibility of using monocyte-derived dendritic cells obtained from cryopreserved cells for DC-based vaccines. J Immunol Methods. 2021;498:113133. DOI: 10.1016/j.jim.2021.113133
Goltsev AN, Dubrava TG, Yampolskaya EE, Gayevskaya YA, Babenko NN, Bondarovich NA. Optimization of the method of obtaining immature dendritic cells for therapeutic use. Physiol J. 2018;64(5):33-40.
Kamyshnikov VS. Reference book on clinical and biochemical research and laboratory diagnostics. MEDpress-inform; 2000. p. 64-6.
Novikov AA, Aleksandrova EN, Diatroptova MA, Nasonov EL. Role of cytokines in the pathogenesis of rheumatoid ar-thritis. Rheumatol Sci Pract. 2010;48(2):71-82. DOI: 10.14412/1995-4484-2010-1420
Brennan FM, McInnes IB. Evidence that cytokines play a role in rheumatoid arthritis. J Clin Invest. 2008;118(11):3537-45. DOI: 10.1172/JCI36389
Wang S, Zhou Y, Huang J, Li H, Pang H, Niu D, et al. Advances in experimental models of rheumatoid arthritis. Eur J Immunol. 2023 Jan;53(1):e2249962. DOI: 10.1002/eji.202249962
Donaldson LF, Seckl JR, McQuenn DS. A discrete adjuvant-induced monoarthritis in the rat: effects of adjuvant dose. J Neurosci Methods. 1993;49(1-2):5-10. DOI: 10.1016/0165-0270(93)90103-x
Schurgers E, Billiau A, Matthys P. Collagen-induced arthritis as an animal model for rheumatoid arthritis: focus on interferon-gamma. J Interferon Cytokine Res. 2011;31(12):917-26. DOI: 10.1089/jir.2011.0056
Izquierdo E, Cañete JD, Celis R, Del Rey MJ, Usategui A, Marsal S, et al. Synovial fibroblast hyperplasia in rheumatoid arthritis: clinicopathologic correlations and partial reversal by anti-tumor necrosis factor therapy. Arthritis Rheum. 2011;63(9):2575-83. DOI: 10.1002/art.30433
Markovics A, Rosenthal KS, Mikecz K, Carambula RE, Ciemielewski JC, Zimmerman DH. Restoring the balance between pro-inflammatory and anti-inflammatory cytokines in the treatment of rheumatoid arthritis: new insights from animal models. Biomedicines. 2022;10(1):44. DOI: 10.3390/biomedicines10010044
Alunno A, Carubbi F, Giacomelli R, Gerli R. Cytokines in the pathogenesis of rheumatoid arthritis: new players and therapeutic targets. BMC Rheumatol. 2017;1:3. DOI: 10.1186/s41927-017-0001-8
Yoshida Y, Tanaka T. Interleukin 6 and rheumatoid arthritis. Biomed Res Int. 2014;2014:698313. DOI: 10.1155/2014/698313
Mateen S, Moin S, Shahzad S, Khan AQ. Level of inflammatory cytokines in rheumatoid arthritis patients: Corre-lation with 25-hydroxy vitamin D and reactive oxygen species. PLoS One. 2017;12(6):e0178879. DOI: 10.1371/journal.pone.0178879
Lee SH, Kwon JY, Kim S-Y, Jung KA, Cho M-L. Interferon-gamma regulates infammatory cell death by targeting necroptosis in experimental autoimmune arthritis. Sci Rep. 2017;7(1):10133. DOI: 10.1038/s41598-017-09767-0.
Benham H, Nel HJ, Law SC, Mehdi AM, Street S, Ramnoruth N, et al. Citrullinated peptide dendritic cell immunotherapy in HLA risk genotype-positive rheumatoid arthritis patients. Sci Transl Med. 2015;7(290):290ra87. DOI: 10.1126/scitranslmed.aaa9301
Bell GM, Anderson AE, Diboll J, et al. Autologous tolerogenic dendritic cells for rheumatoid and inflammatory arthritis. Ann Rheum Dis. 2017;76(1):227-34. DOI: 10.1136/annrheumdis-2015-208456
Goltsev AM, Kisielova HH. Justification of therapeutic efficacy of dendritic cells derived from cryopreserved precursors in an adjuvant arthritis model. World Med Biol. 2023;2(84):197-202. DOI: 10.26724/2079-8334-2023-2-84-197-202
Park J-E, Jang J, Choi J-H, Kang M-S, Woo Y-J, Seong Y-R, et al. DC-based immunotherapy combined with low-dose methotrexate effective in the treatment of advanced CIA in mice. J Immunol Res. 2015;2015:834085. DOI: 10.1155/2015/834085
Yang Yi, He Xiao, Zhao R, Guo W, Zhu M, Xing W, et al. Serum IFN-γ levels predict the therapeutic effect of mesenchymal stem cell transplantation in active rheumatoid arthritis. J Transl Med. 2018;16(1):165. DOI: 10.1186/s12967-018-1541-4
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 The Author(s)
This work is licensed under a Creative Commons Attribution 4.0 International License.
The ownership of copyright remains with the Authors.
Authors may use their own material in other publications provided that the Journal is acknowledged as the original place of publication and National Technical University of Ukraine “Igor Sikorsky Kyiv Polytechnic Institute” as the Publisher.
Authors are reminded that it is their responsibility to comply with copyright laws. It is essential to ensure that no part of the text or illustrations have appeared or are due to appear in other publications, without prior permission from the copyright holder.
IBB articles are published under Creative Commons licence:- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under CC BY 4.0 that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
